CIK 0001812364 · Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- 4 Open-market sale See remarks sold 298 shares at $7.70 ($2,295)
- 4 Open-market sale Chief Legal Officer sold 348 shares at $7.70 ($2,680)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale See remarks sold 1,651 shares at $9.64 ($15,916)
- 4 Open-market sale Chief Financial Officer sold 2,005 shares at $9.64 ($19,328)
- 4 Open-market sale President, R&D sold 3,178 shares at $9.64 ($30,636)
- 4 Open-market sale Chief Legal Officer sold 1,929 shares at $9.64 ($18,596)
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Grant or award See remarks acquired 200,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 762,360 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 200,000 shares (grant or award)
- 4 Grant or award President, R&D acquired 300,000 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 200,000 shares (grant or award)
- 424B7 Offering Prospectus
Page 13 of 28 · 556 filings